These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19019404)

  • 1. Mutations at human immunodeficiency virus type 1 reverse transcriptase tryptophan repeat motif attenuate the inhibitory effect of efavirenz on virus production.
    Chiang CC; Wang SM; Tseng YT; Huang KJ; Wang CT
    Virology; 2009 Jan; 383(2):261-70. PubMed ID: 19019404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release.
    Chiang CC; Wang SM; Pan YY; Huang KJ; Wang CT
    J Virol; 2010 Jan; 84(2):976-82. PubMed ID: 19889767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the HIV-1 reverse transcriptase tryptophan repeat motif affect virion maturation and Gag-Pol packaging.
    Chiang CC; Tseng YT; Huang KJ; Pan YY; Wang CT
    Virology; 2012 Jan; 422(2):278-87. PubMed ID: 22104208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 reverse transcriptase stability correlates with Gag cleavage efficiency: reverse transcriptase interaction implications for modulating protease activation.
    Hsieh SH; Yu FH; Huang KJ; Wang CT
    J Virol; 2023 Sep; 97(9):e0094823. PubMed ID: 37671867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.
    Wapling J; Moore KL; Sonza S; Mak J; Tachedjian G
    J Virol; 2005 Aug; 79(16):10247-57. PubMed ID: 16051818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions.
    Mulky A; Sarafianos SG; Jia Y; Arnold E; Kappes JC
    J Mol Biol; 2005 Jun; 349(4):673-84. PubMed ID: 15893326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efavirenz enhances HIV-1 gag processing at the plasma membrane through Gag-Pol dimerization.
    Sudo S; Haraguchi H; Hirai Y; Gatanaga H; Sakuragi J; Momose F; Morikawa Y
    J Virol; 2013 Mar; 87(6):3348-60. PubMed ID: 23302874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles.
    Liao WH; Huang KJ; Chang YF; Wang SM; Tseng YT; Chiang CC; Wang JJ; Wang CT
    J Virol; 2007 May; 81(10):5155-65. PubMed ID: 17344306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation.
    Tachedjian G; Moore KL; Goff SP; Sluis-Cremer N
    FEBS Lett; 2005 Jan; 579(2):379-84. PubMed ID: 15642347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy.
    Bacheler L; Jeffrey S; Hanna G; D'Aquila R; Wallace L; Logue K; Cordova B; Hertogs K; Larder B; Buckery R; Baker D; Gallagher K; Scarnati H; Tritch R; Rizzo C
    J Virol; 2001 Jun; 75(11):4999-5008. PubMed ID: 11333879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of residues in the tryptophan repeat motif for HIV-1 reverse transcriptase dimerization.
    Tachedjian G; Aronson HE; de los Santos M; Seehra J; McCoy JM; Goff SP
    J Mol Biol; 2003 Feb; 326(2):381-96. PubMed ID: 12559908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors.
    Menéndez-Arias L; Betancor G; Matamoros T
    Antiviral Res; 2011 Nov; 92(2):139-49. PubMed ID: 21896288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins.
    Cherry E; Liang C; Rong L; Quan Y; Inouye P; Li X; Morin N; Kotler M; Wainberg MA
    J Mol Biol; 1998 Nov; 284(1):43-56. PubMed ID: 9811541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
    Chen SW; Chiu HC; Liao WH; Wang FD; Chen SS; Wang CT
    Virology; 2004 Jan; 318(2):534-41. PubMed ID: 14972522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
    Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of amino acid residues in HIV-1 reverse transcriptase that are critical for the proteolytic processing of Gag-Pol precursors.
    Nishitsuji H; Yokoyama M; Sato H; Yamauchi S; Takaku H
    FEBS Lett; 2011 Nov; 585(21):3372-7. PubMed ID: 22004763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential impact of the HIV-1 non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme function.
    Xu HT; Oliveira M; Quan Y; Bar-Magen T; Wainberg MA
    J Antimicrob Chemother; 2010 Nov; 65(11):2291-9. PubMed ID: 20852269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein.
    Peters S; Muñoz M; Yerly S; Sanchez-Merino V; Lopez-Galindez C; Perrin L; Larder B; Cmarko D; Fakan S; Meylan P; Telenti A
    J Virol; 2001 Oct; 75(20):9644-53. PubMed ID: 11559796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.